Integrated palliative care in Europe: a qualitative systematic literature review of empirically-tested models in cancer and chronic disease

por Siouta, Naouma, Van Beek, K., van der Eerden, M. E., Preston, N., Hasselaar, J. G., Hughes, S., Garralda, E., Centeno, C., Csikos, A., Groot, M., Radbruch, L., Payne, S., Menten, J.
Publicado 2016

A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer

por Garralda, E., Sukari, A., Lakhani, N.J., Patnaik, A., Lou, Y., Im, S.-A., Golan, T., Geva, R., Wermke, M., de Miguel, M., Palcza, J., Jha, S., Chaney, M., Abraham, A.K., Healy, J., Falchook, G.S.
Publicado 2022

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with ref...

por Ochsenreither, S., Fiedler, W.M., Conte, G.D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, E.
Publicado 2022

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

por Garrido, P., Adjei, A.A., Bajpai, J., Banerjee, S., Berghoff, A.S., Choo, S.P., Felip, E., Furness, A.J.S., Garralda, E., Haanen, J., Letsch, A., Linardou, H., Peters, S., Sessa, C., Tabernero, J., Tsang, J., Yang, J.C-.H., Garassino, M.C.
Publicado 2021

1623P Phase I clinical trials (CT) forge on despite COVID-19

por Bardaji, M.J. Lostes, Aliende, E., Moreno, M., Oberoi, H.K., Braña, I., Saavedra, O., Villar, M. Vieito, Alonso, G., Galvao, V., Carballo, N., Beltran, M., Rovira, P., Cidoncha, I., Manich, C. Saura, Mercade, T. Macarulla, Oaknin, A., Galceran, J. Carles, Felip, E., Garralda, E., Pujol, S. Perez
Publicado 2021

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies

por Berghoff, A.S., Sessa, C., Yang, J.C.-H., Tsourti, Z., Tsang, J., Tabernero, J., Peters, S., Linardou, H., Letsch, A., Haanen, J., Garralda, E., Garassino, M.C., Furness, A.J.S., Felip, E., Dimopoulou, G., Dafni, U., Choo, S.P., Banerjee, S., Bajpai, J., Adjei, A.A., Garrido, P.
Publicado 2021

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey

por Linardou, H., Adjei, A.A., Bajpai, J., Banerjee, S., Berghoff, A.S., Mathias, C. Cerqueira, Choo, S.P., Dent, R., Felip, E., Furness, A.J.S., Garassino, M.C., Garralda, E., Konsoulova-Kirova, A., Letsch, A., Menzies, A.M., Mukherji, D., Peters, S., Sessa, C., Tsang, J., Yang, J.C.-H., Garrido, P.
Publicado 2023

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

por Borazanci, E., Schram, A.M., Garralda, E., Brana, I., Vieito Villar, M., Spreafico, A., Oliva, M., Lakhani, N.J., Hoffman, K., Hallett, R.M., Maetzel, D., Hua, F., Hilbert, J., Giblin, P., Anido, J., Kelly, A., Vickers, P.J., Wasserman, R., Seoane, J., Siu, L.L., Hyman, D.M., Hoff, D.V., Tabernero, J.
Publicado 2022

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

por Simonelli, M., Garralda, E., Eskens, F., Gil-Martin, M., Yen, C.-J., Obermannova, R., Chao, Y., Lonardi, S., Melichar, B., Moreno, V., Yu, M.-L., Bongiovanni, A., Calvo, E., Rottey, S., Machiels, J.-P., Gonzalez-Martin, A., Paz-Ares, L., Chang, C.-L., Mason, W., Lin, C.-C., Reardon, D.A., Vieito, M., Santoro, A., Meng, R., Abbadessa, G., Menas, F., Lee, H., Liu, Q., Combeau, C., Ternes, N., Ziti-Ljajic, S., Massard, C.
Publicado 2022